LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Accueil・Liste d'Actions・NeoGenomics Inc

NeoGenomics Inc

Fermé

9.23 1.54

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

9.19

Max

9.25

Chiffres clés
By Trading Economics
Revenu	-7.2M -17M
Ventes	-3.5M 187M
BPA	0.01
Marge bénéficiaire	-9.164
Employés	2,500
EBITDA	-5.8M -567K

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+61.76% upside

Dividendes
By Dow Jones
Prochains Résultats	28 juil. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-31M 1.1B
Ouverture précédente	7.69
Clôture précédente	9.23

NeoGenomics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 mai 2026, 18:09 UTC

Market Talk

Centralized Crypto Lending Slows in 1Q -- Market Talk

22 mai 2026, 16:54 UTC

Market Talk

Crypto Spot Volumes Fall 14% in April -- Market Talk

22 mai 2026, 14:53 UTC

Market Talk

USDT Build on Binance May Signal Refreshed Crypto Appetite -- Market Talk

22 mai 2026, 11:51 UTC

Market Talk

Bitcoin Dented by U.S. Rate-Rise Bets, Iran War Uncertainty -- Market Talk

22 mai 2026, 07:28 UTC

Market Talk

Bitcoin Falls as Investors Weigh Conflicting Iran War Headlines -- Market Talk

21 mai 2026, 17:04 UTC

Market Talk

SpaceX Revealed as Top 10 Bitcoin Holder -- Market Talk

21 mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

21 mai 2026, 16:08 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21 mai 2026, 16:08 UTC

Market Talk

Zcash Backtracks After Yesterday's Surge -- Market Talk

21 mai 2026, 15:39 UTC

Market Talk

Global Equities Roundup: Market Talk

21 mai 2026, 15:39 UTC

Market Talk

Hyperliquid ETFs Gaining Momentum as Price Soars -- Market Talk

21 mai 2026, 13:52 UTC

Market Talk

Bitcoin Shows Signs of Repeating 2022 Trading Pattern -- Market Talk

21 mai 2026, 07:03 UTC

Market Talk

Bitcoin Falls on Iran War Uncertainty, U.S. Rate Rise Bets -- Market Talk

20 mai 2026, 17:08 UTC

Market Talk

Zcash Benefiting From Investments in 'Production-Grade Privacy' -- Market Talk

20 mai 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

20 mai 2026, 15:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20 mai 2026, 15:51 UTC

Market Talk

Zcash Tears Higher in Mostly Positive Day for Crypto -- Market Talk

20 mai 2026, 15:39 UTC

Market Talk

Bitcoin Support Seen as $76k, Says Bitfinex -- Market Talk

20 mai 2026, 13:08 UTC

Market Talk

Bitcoin Rangebound as ETF Outflows Continue -- Market Talk

20 mai 2026, 12:44 UTC

Market Talk

Bitcoin Gains Slightly as U.S. Stock Futures Rise -- Market Talk

20 mai 2026, 07:25 UTC

Market Talk

Bitcoin Edges Higher But Iran War Uncertainty Limits Gains -- Market Talk

19 mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

19 mai 2026, 15:54 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19 mai 2026, 15:54 UTC

Market Talk

Bitcoin Holders Under Little Pressure to Sell Despite ETF Outflow -- Market Talk

19 mai 2026, 14:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

19 mai 2026, 14:51 UTC

Market Talk

Ethereum Down From Near-Term High -- Market Talk

19 mai 2026, 08:26 UTC

Market Talk

Bitcoin Edges Higher as Oil Price, Bond Yields Fall -- Market Talk

19 mai 2026, 08:26 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

18 mai 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18 mai 2026, 17:22 UTC

Market Talk

Tokenized Assets Expected to be Over $1T By 2030 -- Market Talk

Comparaison

Variation de prix

NeoGenomics Inc prévision

Objectif de Prix

By TipRanks

61.76% hausse

Prévisions sur 12 Mois

Moyen 14.93 USD 61.76%

Haut 25 USD

Bas 11 USD

Basé sur 10 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

10 ratings

Achat

Maintien

Vente

Basé sur 10 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.